STAAR Surgical Total Current Assets 2010-2024 | STAA
STAAR Surgical total current assets from 2010 to 2024. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
STAAR Surgical Annual Total Current Assets
(Millions of US $) |
| 2023 |
$365 |
| 2022 |
$312 |
| 2021 |
$271 |
| 2020 |
$216 |
| 2019 |
$175 |
| 2018 |
$152 |
| 2017 |
$54 |
| 2016 |
$50 |
| 2015 |
$49 |
| 2014 |
$45 |
| 2013 |
$50 |
| 2012 |
$44 |
| 2011 |
$39 |
| 2010 |
$30 |
| 2009 |
$40 |
STAAR Surgical Quarterly Total Current Assets
(Millions of US $) |
| 2024-09-30 |
$397 |
| 2024-06-30 |
$384 |
| 2024-03-31 |
$366 |
| 2023-12-31 |
$365 |
| 2023-09-30 |
$347 |
| 2023-06-30 |
$328 |
| 2023-03-31 |
$313 |
| 2022-12-31 |
$312 |
| 2022-09-30 |
$297 |
| 2022-06-30 |
$296 |
| 2022-03-31 |
$274 |
| 2021-12-31 |
$271 |
| 2021-09-30 |
$264 |
| 2021-06-30 |
$248 |
| 2021-03-31 |
$224 |
| 2020-12-31 |
$216 |
| 2020-09-30 |
$196 |
| 2020-06-30 |
$183 |
| 2020-03-31 |
$172 |
| 2019-12-31 |
$175 |
| 2019-09-30 |
$165 |
| 2019-06-30 |
$159 |
| 2019-03-31 |
$153 |
| 2018-12-31 |
$152 |
| 2018-09-30 |
$147 |
| 2018-06-30 |
$67 |
| 2018-03-31 |
$62 |
| 2017-12-31 |
$54 |
| 2017-09-30 |
$58 |
| 2017-06-30 |
$48 |
| 2017-03-31 |
$49 |
| 2016-12-31 |
$50 |
| 2016-09-30 |
$50 |
| 2016-06-30 |
$49 |
| 2016-03-31 |
$46 |
| 2015-12-31 |
$49 |
| 2015-09-30 |
$48 |
| 2015-06-30 |
$47 |
| 2015-03-31 |
$43 |
| 2014-12-31 |
$45 |
| 2014-09-30 |
$49 |
| 2014-06-30 |
$51 |
| 2014-03-31 |
$51 |
| 2013-12-31 |
$50 |
| 2013-09-30 |
$48 |
| 2013-06-30 |
$44 |
| 2013-03-31 |
$42 |
| 2012-12-31 |
$44 |
| 2012-09-30 |
$42 |
| 2012-06-30 |
$39 |
| 2012-03-31 |
$39 |
| 2011-12-31 |
$39 |
| 2011-09-30 |
$36 |
| 2011-06-30 |
$33 |
| 2011-03-31 |
$30 |
| 2010-12-31 |
$30 |
| 2010-09-30 |
$28 |
| 2010-06-30 |
$28 |
| 2010-03-31 |
$44 |
| 2009-12-31 |
$40 |
| 2009-09-30 |
$40 |
| 2009-06-30 |
$40 |
| 2009-03-31 |
$30 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$1.312B |
$0.322B |
|
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
|
